Your browser doesn't support javascript.
loading
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019.
Castelpietra, Giulio; Knudsen, Ann Kristin Skrindo; Agardh, Emilie E; Armocida, Benedetta; Beghi, Massimiliano; Iburg, Kim Moesgaard; Logroscino, Giancarlo; Ma, Rui; Starace, Fabrizio; Steel, Nicholas; Addolorato, Giovanni; Andrei, Catalina Liliana; Andrei, Tudorel; Ayuso-Mateos, Jose L; Banach, Maciej; Bärnighausen, Till Winfried; Barone-Adesi, Francesco; Bhagavathula, Akshaya Srikanth; Carvalho, Felix; Carvalho, Márcia; Chandan, Joht Singh; Chattu, Vijay Kumar; Couto, Rosa A S; Cruz-Martins, Natália; Dargan, Paul I; Deuba, Keshab; da Silva, Diana Dias; Fagbamigbe, Adeniyi Francis; Fernandes, Eduarda; Ferrara, Pietro; Fischer, Florian; Gaal, Peter Andras; Gialluisi, Alessandro; Haagsma, Juanita A; Haro, Josep Maria; Hasan, M Tasdik; Hasan, Syed Shahzad; Hostiuc, Sorin; Iacoviello, Licia; Iavicoli, Ivo; Jamshidi, Elham; Jonas, Jost B; Joo, Tamas; Jozwiak, Jacek Jerzy; Katikireddi, Srinivasa Vittal; Kauppila, Joonas H; Khan, Moien A B; Kisa, Adnan; Kisa, Sezer; Kivimäki, Mika.
Afiliação
  • Castelpietra G; Outpatient and Inpatient Care Service, Central Health Directorate, Region Friuli Venezia Giulia, Italy.
  • Knudsen AKS; Centre for Disease Burden, Norwegian Institute of Public Health, Bergen, Norway.
  • Agardh EE; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Armocida B; Department of Cardiovascular, Endocrine-metabolic Diseases and Aging, National Institute of Health, Rome, Italy.
  • Beghi M; Department of Mental Health, AUSL Romagna, Ravenna, Italy.
  • Iburg KM; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Logroscino G; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Ma R; Department of Clinical Research in Neurology, Fondazione Cardinale Giovanni Panico Hospital, Tricase, Italy.
  • Starace F; Institute for Health Metrics and Evaluation, Department of Health Metrics Sciences, University of Washington, Seattle, WA, USA.
  • Steel N; Department of Mental Health & Drug Abuse, AUSL Modena, Modena, Italy.
  • Addolorato G; Department of Primary Care and Public Health, University of East Anglia, Norwich, UK.
  • Andrei CL; Public Health England, London, UK.
  • Andrei T; Department of Internal Medicine, Catholic University of Rome, Rome, Italy.
  • Ayuso-Mateos JL; Cardiology Department Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Banach M; Department of Statistics and Econometrics Bucharest Carol Davila University of Economic Studies, Bucharest, Romania.
  • Bärnighausen TW; CIBERSAM, Institute of Health Carlos III, Madrid, Spain.
  • Barone-Adesi F; Department of Psychiatry, Universidad Autónoma de Madrid (Autonomous University of Madrid), Madrid, Spain.
  • Bhagavathula AS; Department of Hypertension, Medical University of Lodz, Lodz, Poland.
  • Carvalho F; Polish Mothers' Memorial Hospital Research Institute, Lodz, Poland.
  • Carvalho M; Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, Germany.
  • Chandan JS; T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Chattu VK; Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Couto RAS; Department of Social and Clinical Pharmacy, Charles University, Hradec Kralova, Czech Republic.
  • Cruz-Martins N; Institute of Public Health, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Dargan PI; Research Unit on Applied Molecular Biosciences (UCIBIO), University of Porto, Porto, Portugal.
  • Deuba K; Research Unit on Applied Molecular Biosciences (UCIBIO), University of Porto, Porto, Portugal.
  • da Silva DD; Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal.
  • Fagbamigbe AF; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Fernandes E; Faculty of Medical Sciences, University of the West Indies, St Augustine, Trinidad and Tobago.
  • Ferrara P; Independent Consultant, Athens, Greece.
  • Fischer F; Department of Chemical Sciences, University of Porto, Porto, Portugal.
  • Gaal PA; Department of Medicine (Prof N Cruz-Martins PhD), University of Porto, Porto, Portugal.
  • Gialluisi A; Department of Health Sciences Institute of Research and Advanced Training in Health Sciences and Technologies (CESPU), Famalicão, Portugal.
  • Haagsma JA; Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Haro JM; Department of Clinical Toxicology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Hasan MT; National Centre for AIDS and STD Control, Save the Children, Kathmandu, Nepal.
  • Hasan SS; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Hostiuc S; Laboratory of Toxicology, University of Porto, Porto, Portugal.
  • Iacoviello L; Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria.
  • Iavicoli I; Population and Behavioural Sciences, University of St Andrews, St Andrews, UK.
  • Jamshidi E; Associated Laboratory for Green Chemistry (LAQV), University of Porto, Porto, Portugal.
  • Jonas JB; Research Center on Public Health, University of Milan Bicocca, Monza, Italy.
  • Joo T; Institute of Public Health, Charité Universitätsmedizin Berlin (Charité Medical University Berlin), Berlin, Germany.
  • Jozwiak JJ; Health Services Management Training Centre, Semmelweis University, Budapest, Hungary.
  • Katikireddi SV; Department of Applied Social Sciences, Sapientia Hungarian University of Transylvania, Târgu-Mures, Romania.
  • Kauppila JH; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.
  • Khan MAB; Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Kisa A; Research Unit, University of Barcelona, Barcelona, Spain.
  • Kisa S; Biomedical Research Networking Center for Mental Health Network (CiberSAM), Barcelona, Spain.
  • Kivimäki M; Department of Pharmacy, University of Huddersfield, Huddersfield, UK.
Lancet Reg Health Eur ; 16: 100341, 2022 May.
Article em En | MEDLINE | ID: mdl-35392452
Background: Mental health is a public health issue for European young people, with great heterogeneity in resource allocation. Representative population-based studies are needed. The Global Burden of Disease (GBD) Study 2019 provides internationally comparable information on trends in the health status of populations and changes in the leading causes of disease burden over time. Methods: Prevalence, incidence, Years Lived with Disability (YLDs) and Years of Life Lost (YLLs) from mental disorders (MDs), substance use disorders (SUDs) and self-harm were estimated for young people aged 10-24 years in 31 European countries. Rates per 100,000 population, percentage changes in 1990-2019, 95% Uncertainty Intervals (UIs), and correlations with Sociodemographic Index (SDI), were estimated. Findings: In 2019, rates per 100,000 population were 16,983 (95% UI 12,823 - 21,630) for MDs, 3,891 (3,020 - 4,905) for SUDs, and 89·1 (63·8 - 123·1) for self-harm. In terms of disability, anxiety contributed to 647·3 (432-912·3) YLDs, while in terms of premature death, self-harm contributed to 319·6 (248·9-412·8) YLLs, per 100,000 population. Over the 30 years studied, YLDs increased in eating disorders (14·9%;9·4-20·1) and drug use disorders (16·9%;8·9-26·3), and decreased in idiopathic developmental intellectual disability (-29·1%;23·8-38·5). YLLs decreased in self-harm (-27·9%;38·3-18·7). Variations were found by sex, age-group and country. The burden of SUDs and self-harm was higher in countries with lower SDI, MDs were associated with SUDs. Interpretation: Mental health conditions represent an important burden among young people living in Europe. National policies should strengthen mental health, with a specific focus on young people. Funding: The Bill and Melinda Gates Foundation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article